Clinical Trial

Extended Azithromycin Treatment in Prelabor Rupture of Membranes

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn whether adding extra doses of azithromycin to the standard antibiotic treatment for preterm prelabor rupture of membranes may improve pregnancy outcomes for patients between 22 weeks and 28 weeks gestational age. Researchers will compare the standard antibiotic treatment to the standard antibiotic treatment with additional doses of azithromycin. Participants will: * Be randomly assigned to one of two groups: * The standard antibiotic treatment * The standard antibiotic treatment plus 7 additional doses of oral azithromycin 500 mg every other day. * Participants will be asked to complete a survey regarding their experience and side effects.
Trial Details
NCT Number NCT07669207
Lead Sponsor Alexa Henderson
Conditions Preterm Prelabor Rupture of Membranes, PPROM
Enrollment 30 participants
Start Date 2026-08
Primary Completion 2028-05 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-12